case_images: PMC10904938_01
case_images: Changes in FEV1 pre- and post-initiation of benralizumab.. FEV1: Forced expiratory volume in the first second.
case_images: f1000research-12-145643-g0000.jpg
case_images: PMC10904938_01_f1000research-12-145643-g0000.jpg
case_images: f1
case_images: Figure 1 shows the changes in FEV1 after benralizumab therapy.
case_images: PMC10904938_02
case_images: Variation in eosinophil levels after treatment with benralizumab.. AEC: Absolute eosinophil count.
case_images: f1000research-12-145643-g0001.jpg
case_images: PMC10904938_02_f1000research-12-145643-g0001.jpg
case_images: f2
case_images: Figure 2 illustrates the variation in eosinophil levels after treatment with benralizumab after 6 months of benralizumab initiation.
case_images: PMC10904938_03
case_images: a: Change in ACT scores after initiation of benralizumab.
  ACT: Asthma control test. b: Change in absolute eosinophil count after initiation of benralizumab.
case_images: f1000research-12-145643-g0002.jpg
case_images: PMC10904938_03_f1000research-12-145643-g0002.jpg
case_images: f3
case_images: ACT score from 13 to 23 at the 6-month follow-up, which was a clinically meaningful increase ( Figure 3a). Absolute eosinophil counts gradually reduced from 360 cells/muL to 0 by the sixth month ( Figure 3b).
case_images: PMC10904938_04
case_images: Change in FVC (L) and FEV1 (% predicted) after initiation of benralizumab.. FEV1: Forced expiratory volume in the first second; FVC: Forced vital capacity.
case_images: f1000research-12-145643-g0003.jpg
case_images: PMC10904938_04_f1000research-12-145643-g0003.jpg
case_images: f4
case_images: After benralizumab treatment, FEV1 increased to 78% and the ACT score increased to 17, demonstrating improved lung function and QoL ( Figure 4).
case_images: PMC10904938_05
case_images: PMC10904938_06
case_images: Change in ACT score after initiation of benralizumab.. ACT: Asthma control test.
case_images: f1000research-12-145643-g0004.jpg
case_images: PMC10904938_06_f1000research-12-145643-g0004.jpg
case_images: f5
case_images: There was a significant improvement in the QoL (ACT improved from 17 to 20, Figure 5) with minimal changes in lung function.